FGFR2 and cholangiocarcinoma: CEPBB and FGFR2 expression were detected at the liver parenchyma (LP) and bile duct (BD) (LP+ve; BD+ve), or only at the liver parenchyma (LP+ve; BD-ve), or undetected (LP-ve; BD-ve) in CC livers (Fig 3).